Biosyncora - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 158,276 | 158,066 | 393,447 | 600,113 | 434,329 | 518,869 | 977,778 |
| Profit before tax | 1,420 | 98 | 56,609 | 43,780 | 19,158 | 47,892 | 212,350 |
| Net profit | 1,454 | 72 | 56,609 | 37,213 | 16,266 | 38,905 | 179,781 |
| Equity | 50,306 | 50,404 | 107,726 | 121,409 | 137,676 | 166,789 | 217,746 |
| Liabilities | 20,638 | 16,462 | 39,294 | 41,223 | 64,237 | 196,986 | 200,695 |
| Non-current assets | 5,740 | 2,542 | 3,981 | 58,520 | 50,155 | 202,134 | 149,003 |
| Current assets | 65,204 | 64,324 | 143,039 | 91,972 | 136,666 | 131,582 | 288,816 |
| Total assets | 70,944 | 66,866 | 147,020 | 150,492 | 186,821 | 333,716 | 437,819 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 54,309 | 127,415 | 177,013 |
| Social insurance contributions | - | - | - | - | 21,280 | 17,906 | 23,608 |
|
Financial indicators
|
|||||||
| Revenue change y/y | +3.7% | -0.1% | - | +52.5% | -27.6% | +19.5% | +88.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.0% | 0.1% | 38.5% | 24.7% | 8.7% | 11.7% | 41.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 2.9% | 0.1% | 52.5% | 30.7% | 11.8% | 23.3% | 82.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.9% | 0.0% | 14.4% | 6.2% | 3.7% | 7.5% | 18.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.9% | 0.1% | 14.4% | 7.3% | 4.4% | 9.2% | 21.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.3 | 0.4 | 0.3 | 0.5 | 1.2 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 40,411 | 33,871 | 80,023 | 87,822 | 86,866 | 129,717 | 202,300 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biosyncora - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-08-19 | 2024-08-20 | 1.76 |
| 2024-07-24 | 2024-08-11 | 1.76 |
| 2024-04-16 | 2024-04-18 | 1462.82 |
| 2023-10-25 | 2023-11-13 | 1.95 |
| 2023-07-24 | 2023-07-24 | 4.12 |
| 2023-07-18 | 2023-07-23 | 961.13 |
| 2023-06-16 | 2023-06-19 | 998.56 |
| 2023-05-16 | 2023-05-17 | 2519.71 |
| 2021-12-16 | 2021-12-26 | 5.46 |
| 2021-11-16 | 2021-12-07 | 5.46 |
| 2021-11-05 | 2021-11-08 | 5.46 |
Biosyncora - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 1.76 |
| 2026-03-19 | 2026-03-27 | 0.04 |
| 2026-02-21 | 2026-02-21 | 37.26 |
| 2025-12-31 | 2025-12-31 | 0.49 |
| 2025-12-08 | 2025-12-08 | 32.7 |
| 2025-12-01 | 2025-12-07 | 32.65 |
| 2025-11-30 | 2025-11-30 | 32.26 |
| 2025-09-28 | 2025-09-29 | 39721.99 |
| 2025-07-01 | 2025-07-20 | 9.44 |
| 2025-05-01 | 2025-05-24 | 0.3 |
| 2025-03-28 | 2025-04-17 | 4.57 |
| 2025-03-27 | 2025-03-27 | 0.06 |
| 2025-03-20 | 2025-03-20 | 57.58 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.